Le Lézard
Classified in: Health
Subject: PLW

20/20NOW Announces Efforts To Protect Its Patents Against Infringement


NEW YORK, June 5, 2018 /PRNewswire/ -- 20/20NOW, the pioneer and innovator of Ocular Telehealth, has initiated legal action and other efforts to protect its patents against infringement. 20/20NOW has filed a lawsuit in New York Eastern District Federal Court against Digital Optometrics, claiming infringement of 20/20NOW's intellectual property. The company also intends on filing for a Post Grant Review of Digital Optometrics Patent with the U.S. Patent Office. The company is confident that the recently issued Digital Optometrics Patent will be found invalid.

According to telehealth industry veteran and 20/20NOW CEO Chuck Scott, "20/20NOW has spent numerous years and invested considerable resources developing the know-how and capabilities to conduct comprehensive, in-office vision and eye health testing via telehealth. This includes the issuance of multiple patents covering not only our proprietary exam software but also the systems and methods for testing patient visual acuity and eye health via telehealth.  We simply can't afford to permit, and allow others to copy and use our intellectual property."

Scott shared further, "20/20NOW is dedicated to providing patients access to care, while enabling our clients to conduct high quality, in-office comprehensive eye exams via telehealth.  As such, we have a duty to our shareholders, investors and customers to protect our intellectual property against misuse. As such, we plan to aggressively defend our intellectual property against infringement both now and in the future."

About 20/20NOW
20/20NOW is the pioneer and innovator of ocular telehealth.  Using state-of-the-art technology, proprietary software and patented exam processes, 20/20NOW provides comprehensive eye exams, including eye health screenings, via telehealth. The company's telehealth model allows eye care professionals and optical retailers to provide their patients with increased access to high quality eye exams at a lower cost. 20/20NOW is currently licensed/operating in 17 states.  Over 2.5 million eye exams have been performed worldwide using its proprietary exam software. For more information visit: www.for2020now.com.

20/20NOW
New York, NY
844-843-2020
[email protected]

 

SOURCE 20/20NOW


These press releases may also interest you

at 09:15
n-Lorem, a nonprofit foundation, announced a new partnership with Hongene Biotech Corporation that supports n-Lorem's efforts to discover and provide personalized experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1...

at 09:11
For over 30 years Protocall's behavioral health contact center, HelpNow, has set industry standards for round-the-clock access to high-quality crisis care. Received calls are documented within Protocall's custom database and sent to the caller's care...

at 09:10
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of a Phase II clinical study in minimal residual disease positive (MRD+) HPV-driven head and neck cancer. The study will be led by...

at 09:06
Memora Health, the leading intelligent care enablement platform, today announced an expansion of its leadership team with the addition of Divya Bhat as Chief Product Officer and Herman Ng as Chief Financial Officer. Divya and Herman bring unique...

at 09:05
Quantum Health, the leading consumer healthcare navigation and care coordination company, announced today the launch of its new end-to-end care management solution, Premier Oncology, tailored for employers and their members diagnosed with cancer....

at 09:05
United Therapeutics Corporation , a public benefit corporation, today announced the world's first successful transplant of a UThymoKidneytm, which the company produced, into a living person on April 12, 2024. This transplant represents several...



News published on and distributed by: